Gemini Therapeutics (GMTX) Stock Chart & Stock Price History $74.36 -2.62 (-3.40%) As of 10/16/2025 Add Compare Share Share Chart Stock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsTrendsBuy This Stock Gemini Therapeutics Stock Price Performance The Gemini Therapeutics (GMTX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 54.95%, with a year-to-date return of 20.71%. In the past month, the stock has increased 23.24%, reflecting recent market activity. As of the latest close, Gemini Therapeutics traded at $76.98 with a market cap of $3.34 billion and volume of 423,050 shares. Receive GMTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Gemini Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+5.10%1 Month Performance+23.24%3 Month Performance+29.68%Year-To-Date Performance+20.71%1 Year Performance+54.95% GMTX Stock Chart for Friday, October, 17, 2025 GMTX Chart by TradingView Gemini Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/17/2025$76.98$74.36-3.40%$77.95$73.88274,344 shs$3.22 billion10/16/2025$73.00$76.98+5.45%$78.17$72.31423,050 shs$3.34 billion10/15/2025$71.96$73.00+1.45%$73.53$70.97344,700 shs$3.16 billion10/14/2025$69.90$71.96+2.95%$72.31$69.51428,231 shs$3.12 billion10/13/2025$69.90$69.90$70.89$68.82310,503 shs$3.03 billion10/10/2025$70.28$70.75+0.67%$71.13$69.79509,349 shs$3.07 billion10/09/2025$67.89$70.28+3.52%$72.68$67.22668,396 shs$3.05 billion10/08/2025$69.28$67.89-2.01%$69.51$67.31318,010 shs$2.94 billion10/07/2025$67.78$69.28+2.21%$69.87$67.44360,329 shs$3.00 billion10/06/2025$67.78$67.78$67.92$65.43272,220 shs$2.94 billion Get the Latest News and Ratings for GMTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Gemini Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/03/2025$67.04$65.86-1.76%$67.28$65.26367,291 shs$2.85 billion10/02/2025$66.08$67.04+1.45%$68.79$65.88475,637 shs$2.90 billion10/01/2025$65.06$66.08+1.57%$66.58$64.89375,991 shs$2.86 billion09/30/2025$65.55$65.06-0.75%$68.43$64.40398,594 shs$2.82 billion09/29/2025$65.55$65.55$65.94$61.97352,247 shs$2.84 billion09/26/2025$62.39$62.50+0.18%$62.88$60.49227,824 shs$2.71 billion09/25/2025$62.16$62.39+0.37%$63.53$61.04172,194 shs$2.70 billion09/24/2025$61.50$62.16+1.08%$63.29$61.24327,715 shs$2.69 billion09/23/2025$60.79$61.50+1.16%$62.51$59.74235,643 shs$2.66 billion09/22/2025$60.79$60.79$62.98$60.25878,158 shs$2.63 billion09/19/2025$61.04$62.63+2.61%$62.64$60.58516,904 shs$2.71 billion09/18/2025$60.34$61.04+1.15%$63.54$59.65418,250 shs$2.64 billion09/17/2025$59.90$60.34+0.73%$61.51$59.66294,953 shs$2.61 billion09/16/2025$59.82$59.90+0.13%$60.12$58.36318,640 shs$2.60 billion Related Companies Viatris Stock Price Chart Dr. Reddy's Laboratories Stock Price Chart Roivant Sciences Stock Price Chart Moderna Stock Price Chart Qiagen Stock Price Chart BridgeBio Pharma Stock Price Chart Elanco Animal Health Stock Price Chart Regencell Bioscience Stock Price Chart Verona Pharma PLC American Depositary Share Stock Price Chart Revolution Medicines Stock Price Chart Receive GMTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Gemini Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:GMTX) was last updated on 10/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gemini Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Gemini Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
